News Focus
News Focus
icon url

Relic

01/13/20 5:46 PM

#240754 RE: Biobillionair #240745

BB
Will we hear updates on the trial or will we just hear the verdict at the end?
icon url

invest2992

01/13/20 7:29 PM

#240770 RE: Biobillionair #240745

Have any of the PCSK9 drugs shown any CV benefits other than lowering lipid profiles. does it clear up plaque? I'm on Repatha and it has really lowered my LDL and trig numbers but would like to think its also reducing plaque and has been shown to reduce CVD risk. I get my latest blood test results tomorrow which I'll share.
icon url

amarinbullfromchicago

01/13/20 11:15 PM

#240822 RE: Biobillionair #240745

I think Azn is a great European partner at this point. Seems like a no brainer for them to scrap epinova and replace it with amarin (probably relatively cheaply to be honest, with royalties of course) in Europe. Imagine if they would have had a decently competent consult them tell them that before they spent over half a billion on their trial...you can buy the rights to amarin Europe for 2-4x the price a failed trial will cost you.

With acasti and epinova out, it seems almost impossible we don’t see BO offers before H2 this year. The more the better, bring em on! I think your number was $210 a share?